HHS awarded a contract for $97 million to Sanofi Pasteur to develop cell culture-based influenza vaccines for the U.S.
On Apr. 3, 2005, Sanofi pasteur was awarded a five-year $97 million contract from the U.S. Health and Human Services Department (HHS) to speed the production process for new cell culture influenza vaccines in the U.S. and the design of a U.S.-based cell-culture vaccine manufacturing facility.
Sanofi pasteur conducted the work at its Swiftwater, PA, and Marcy L’Etoile, France, sites to support this critical project.
Tags:
Source: University of Minnesota, Center for Infectious Disease Research and Policy
Credit:
